Rai V., et al.
"Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery"
Journal of Controlled Release Volume 270, 28 January 2018, Pages 203-225
MINOXIDIL-FINASTERIDE TOPICAL NANOEMULSION
•Water based formulation (oil-in-water nanoemulsion)
•No propylene glycol, about 6% of alcohol
•Prepared by dilution of self-nanoemulsifying composition
•Droplet size – about 20 nm
•Drug loading: Minoxidil – 2 and 4%, Finasteride – 0.5, 0.25% or 0.1% •Minoxidil association with oil droplets: 40-60%
•Finasteride association with oil droplets: 97-100%
•Room temperature (RT) – stable •Refrigerated (+4oC) – stable
•Particle size and size distribution – stable
Visible effect (hair growth improvement) – in 8-10 weeks instead of 4-8 months
PHARCON Inc.
423 - 7250 Keele Street, Vaughan, Ontario L4K 2J8, Canada
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.